Insider Selling: CME Group Inc. (CME) Insider Sells 2,600 Shares of Stock
CME Group Inc. (NASDAQ:CME) insider Sunil Cutinho sold 2,600 shares of CME Group stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $139.57, for a total value of $362,882.00. Following the transaction, the insider now owns 22,301 shares of the company’s stock, valued at approximately $3,112,550.57. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
CME Group Inc. (CME) traded down $0.60 during trading on Monday, hitting $139.49. The stock had a trading volume of 924,300 shares, compared to its average volume of 1,357,516. CME Group Inc. has a 1-year low of $111.19 and a 1-year high of $141.44. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $47,650.00, a price-to-earnings ratio of 29.18, a P/E/G ratio of 2.86 and a beta of 0.71.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. The business had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.05 earnings per share. equities research analysts expect that CME Group Inc. will post 4.78 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Friday, December 8th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 annualized dividend and a yield of 1.89%. CME Group’s dividend payout ratio is presently 59.86%.
COPYRIGHT VIOLATION WARNING: “Insider Selling: CME Group Inc. (CME) Insider Sells 2,600 Shares of Stock” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.thecerbatgem.com/2017/11/20/insider-selling-cme-group-inc-cme-insider-sells-2600-shares-of-stock.html.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Eqis Capital Management Inc. lifted its position in CME Group by 4.5% in the second quarter. Eqis Capital Management Inc. now owns 3,051 shares of the financial services provider’s stock valued at $382,000 after purchasing an additional 130 shares during the period. Whittier Trust Co. increased its holdings in CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after buying an additional 27 shares in the last quarter. Skylands Capital LLC increased its holdings in CME Group by 2.6% in the second quarter. Skylands Capital LLC now owns 23,400 shares of the financial services provider’s stock valued at $2,931,000 after buying an additional 600 shares in the last quarter. Opera Trading Capital purchased a new position in CME Group in the second quarter valued at about $3,131,000. Finally, Rothschild Investment Corp IL purchased a new position in CME Group in the second quarter valued at about $624,000. Institutional investors own 82.58% of the company’s stock.
Several brokerages recently weighed in on CME. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Barclays PLC lifted their price target on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research note on Tuesday, October 10th. UBS AG reiterated a “buy” rating and set a $135.00 price objective (up from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Royal Bank Of Canada boosted their price objective on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research note on Monday, October 16th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 price objective on shares of CME Group in a research note on Friday, August 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $141.75.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.